FDA Inspection
Guilin Pharmaceutical Co., Ltd.Guilin Pharmaceutical Co., Ltd. – FDA Inspection, Jul 19, 2018
Record Details
This FDA Inspection record concerns Guilin Pharmaceutical Co., Ltd., with an inspection on July 19, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b4eb333f-6776-4112-b186-4dad9d53ea0e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1061489
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Guilin Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 2, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Guilin Pharmaceutical Co., Ltd.
- FDA Inspection 1217732 - 2023-08-18
- FDA Inspection 920262 - 2015-03-13
- FDA Inspection 748950 - 2011-09-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.